FindTrial
Sign In

The application of low-dose of low-concentration and isobaric Ropivacaine in ERAS after cesarean section

The application of low-dose of low-concentration and isobaric Ropivacaine in ERAS after cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010941
Enrollment
Unknown
Registered
2017-03-21
Start date
2017-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

maternal

Interventions

1:isobaric Ropivacaine, 0.275% 8.25mg
2:isobaric Ropivacaine, 0.4%, 8.25mg
3:isobaric Ropivacaine, 0.4%, 12mg

Sponsors

Cangzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients of Anesthesiologist (ASA) grade I or II, aged 20-35 years, weighed 65-80kg, primiparas with singleton were included in this study

Exclusion criteria

Exclusion criteria: Patients with pregnancy complications including Gestational Diabetes Mellitus (GDM), gestational hypertension, placenta previa were excluded. Also patients with contraindication of intravertebral anesthesia or with a history of hypertension cardiomyopathy, fetal heart rate changes or abnormal were excluded.

Design outcomes

Primary

MeasureTime frame
postoperative recovery;—

Secondary

MeasureTime frame
Effect of intraoperative;—

Countries

China

Contacts

Public ContactJiao Baojie

Department of Anesthesiology, Central Hospital of Cangzhou

470636835@qq.com+86 18031792997

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026